|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review |
 |
Ramipril
significantly reduced the relative risk of each component of the composite
end point, as well as total mortality in the MICRO-HOPE diabetes substudy.
Notably, these findings are consistent with the overall findings from the landmark HOPE study. Data from: HOPE Study Investigators. Lancet. 2000;355:253-259.
|